Additional file 10 of Anti-Toxoplasma gondii efficacy of beta, beta-dimethylacrylshikonin and isobutyrylshikonin in vitro and in vivo

Additional file 10: Figure S8. Statistics of KEGG pathway enrichments of the differential metabolites during monomer treatment in comparison with control. Rich factor is the ratio of the differential metabolites in a given pathway to the total number of metabolites in that pathway, and a higher rich factor suggests a greater degree of enrichment. The size of bubbles in the figure represents the number of significantly differential metabolites (NM) enriched to the corresponding pathway. q value indicates the adjusted p value.